S'identifier

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to increased drug concentration at the receptor site, enhancing the strength of the biological response. The graded dose-response curve is a graphical representation that showcases the correlation between the drug's concentration and the extent of the resultant response. The hyperbolic curve demonstrates that the magnitude of the response gradually increases with the increase in drug dose. The maximum effect of the drug is observed once the receptors attain complete saturation. Sigmoidal curves emerge upon the semi-logarithmic plotting of hyperbolic curves, and these curves are used for depicting drug efficacy and potency. Potency is gauged by evaluating the drug concentration required to reach half of the maximum effect, represented by the EC50 value. Conversely, efficacy is a measure of the drug's ability to produce a maximal therapeutic effect, which is determined by the Emax value.

Tags
Dose response RelationshipAgonistsDrug receptor ComplexesPharmacologic ResponseReceptor ActivationGraded Dose response CurveDrug ConcentrationBiological ResponseHyperbolic CurveSigmoidal CurvesDrug EfficacyDrug PotencyEC50 ValueEmax Value

Du chapitre 4:

article

Now Playing

4.8 : Dose-Response Relationship: Overview

Pharmacodynamics

2.7K Vues

article

4.1 : Principes de l’action des médicaments

Pharmacodynamics

5.5K Vues

article

4.2 : Cibles d’action médicamenteuse : Vue d’ensemble

Pharmacodynamics

5.2K Vues

article

4.3 : Transduction du signal : Vue d’ensemble

Pharmacodynamics

8.0K Vues

article

4.4 : Mécanisme du transducteur : récepteurs couplés aux protéines G

Pharmacodynamics

1.6K Vues

article

4.5 : Récepteur de canal ionique ligand-dépendant : mécanisme de déclenchement

Pharmacodynamics

1.9K Vues

article

4.6 : Mécanisme du transducteur : récepteurs enzymatiques

Pharmacodynamics

2.2K Vues

article

4.7 : Mécanisme du transducteur : récepteurs nucléaires

Pharmacodynamics

1.2K Vues

article

4.9 : Relation dose-réponse : puissance et efficacité potentielle

Pharmacodynamics

3.9K Vues

article

4.10 : Relation dose-réponse : sélectivité et spécificité

Pharmacodynamics

6.1K Vues

article

4.11 : Indice thérapeutique

Pharmacodynamics

3.8K Vues

article

4.12 : Interaction médicament-récepteur : agoniste

Pharmacodynamics

2.2K Vues

article

4.13 : Interaction médicament-récepteur : antagoniste

Pharmacodynamics

2.4K Vues

article

4.14 : Effets combinés des drogues : antagonisme

Pharmacodynamics

7.5K Vues

article

4.15 : Effets combinés des médicaments : synergie

Pharmacodynamics

3.0K Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.